Sandoz Bio 100 targets 100+ biosimilars by 2040
Sandoz’s Bio 100 plan targets over 100 biosimilars by 2040, alongside doubling net sales by 2035 and shifting to a biosimilar-led, vertically integrated model.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.